SCHEMBL8543734

SCHEMBL8543734

Fc1cccc(C2CNc3ccccc32)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 5/20 0.46
HTR2C P28335 5/20 0.46
HTR2B P41595 5/20 0.46
HRH3 Q9Y5N1 4/20 0.46
JAK2 O60674 2/20 0.42
PKM P14618 1/20 0.42
CYP19A1 P11511 1/20 0.41
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5871368 0.83 PRCP (0.42) HTR2AHTR2CHTR2BHRH3JAK2
SCHEMBL4001774 0.82 MEN1 (0.52) KDM4EMEN1KMT2AALDH1A1CYP3A4
SCHEMBL6587573 0.82 SLC6A3 (0.48) HTR2AHTR2CHTR2BHRH3SLC6A2
SCHEMBL8485182 0.82 DRD2 (0.41) HTR2AHTR2CHTR2BL3MBTL1MEN1
SCHEMBL21856329 0.81 HTR2C (0.48) HTR2AHTR2CHTR2BHRH3
Hydrochloric Acid SCHEMBL11553849 0.80 MEN1 (0.50) KDM4EMEN1KMT2AMAPK1CYP3A4
SCHEMBL8540341 0.80 SLC6A2 (0.42) PKMCYP19A1SLC6A2SLC6A4SLC6A3
SCHEMBL21958808 0.79 HTR2C (0.41) HTR2AHTR2CHTR2BHRH3
SCHEMBL8130957 0.78 GID4 (0.53) HTR2AHTR2CHTR2BCYP19A1KDM4E
Formamide SCHEMBL11551135 0.73 MEN1 (0.44) SLC6A3MEN1KMT2ACYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0721949-B1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE CO (JP) 1998-01-07 EP disclosed
US-5677326-A GASTROINTESTINAL DISORDERS TOKYO TANABE COMPANY LIMITED (JP) 1997-10-14 US disclosed
EP-0721949-A1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE COMPANY LIMITED (JP) 1996-07-17 EP disclosed